AU7883291A - Nicotinylalanine as a therapeutic agent acting on the central nervous system - Google Patents

Nicotinylalanine as a therapeutic agent acting on the central nervous system

Info

Publication number
AU7883291A
AU7883291A AU78832/91A AU7883291A AU7883291A AU 7883291 A AU7883291 A AU 7883291A AU 78832/91 A AU78832/91 A AU 78832/91A AU 7883291 A AU7883291 A AU 7883291A AU 7883291 A AU7883291 A AU 7883291A
Authority
AU
Australia
Prior art keywords
nicotinylalanine
nervous system
central nervous
therapeutic agent
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU78832/91A
Other languages
English (en)
Inventor
Flavio Moroni
Roberto Pellicciari
Trevor W Stone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Publication of AU7883291A publication Critical patent/AU7883291A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU78832/91A 1990-05-24 1991-05-21 Nicotinylalanine as a therapeutic agent acting on the central nervous system Abandoned AU7883291A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20418/90 1990-05-24
IT02041890A IT1248486B (it) 1990-05-24 1990-05-24 Agente terapeutico ad attivita' sul sistema nervoso centrale

Publications (1)

Publication Number Publication Date
AU7883291A true AU7883291A (en) 1991-12-10

Family

ID=11166634

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78832/91A Abandoned AU7883291A (en) 1990-05-24 1991-05-21 Nicotinylalanine as a therapeutic agent acting on the central nervous system

Country Status (8)

Country Link
EP (1) EP0532545A1 (2)
JP (1) JPH05507086A (2)
AU (1) AU7883291A (2)
BR (1) BR9106500A (2)
CA (1) CA2083507A1 (2)
HU (1) HUT64695A (2)
IT (1) IT1248486B (2)
WO (1) WO1991017750A1 (2)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0684238A3 (en) * 1994-04-27 1997-01-15 Hoffmann La Roche Process for the preparation of dicarboxamides.
US5536867A (en) * 1994-04-27 1996-07-16 Hoffmann-La Roche Inc. Process for the manufacture of dicarboxamides
JPH11501934A (ja) * 1995-03-14 1999-02-16 シャスカン，エドワード・ジー ニコチニルアラニンと、グリシン抱合の阻害薬又はビタミンｂ６とを含む組成物
CN111164071A (zh) * 2017-09-28 2020-05-15 株式会社Lg化学 用于合成药物的中间体化合物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3649649A (en) * 1967-07-10 1972-03-14 Nisso Kako Co Ltd Fluoran derivatives and preparation thereof
FR1596106A (2) * 1968-12-13 1970-06-15
US4065566A (en) * 1975-04-17 1977-12-27 Interx Research Corporation N-Nicotinoyl-3,4-dinicotinoyloxy-L-phenylalanine and derivatives pharmaceutical compositions and methods containing same

Also Published As

Publication number Publication date
IT1248486B (it) 1995-01-19
WO1991017750A1 (en) 1991-11-28
JPH05507086A (ja) 1993-10-14
HU9203634D0 (en) 1993-03-29
EP0532545A1 (en) 1993-03-24
CA2083507A1 (en) 1991-11-25
HUT64695A (en) 1994-02-28
BR9106500A (pt) 1993-05-25
IT9020418A0 (2) 1990-05-24
IT9020418A1 (it) 1991-11-24

Similar Documents

Publication Publication Date Title
CA1328658C (en) 3-indolepyruvic acid derivatives and pharmaceutical use thereof
JP5127093B2 (ja) カルニチンパルミトイル−トランスフェラーゼの可逆的阻害活性を有する化合物
EP0662948B1 (en) 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity
EP0447285A1 (fr) Nouveaux dérivés à structure naphtalénique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP2030615A2 (en) Ribonucleotide reductase inhibitors for use in the treatment or prevention of neuroinflammatory or autoimmune diseases
JP2001511172A (ja) 特に神経興奮薬性アミノ酸に感受性をもつ中枢神経系受容体のエフェクターを構成する化合物、その製造およびその生物学的利用
US4206232A (en) Relieving hypertension with carboxyalkylacylamino acids
AU2009269842B2 (en) Use of indole derivatives as NURR-1 activators for treating Parkinson's disease
EP0888289A1 (en) Anticonvulsant enantiomeric amino acid derivatives
FR2934267A1 (fr) Derives aminophosphiniques utiles dans le traitement de la douleur
JP2009545549A (ja) Ｃｐｔ阻害剤としての４−トリメチルアンモニウム−３−アミノブチレートおよび４−トリメチルフォスフォニウム−３−アミノブチレート誘導体
AU7883291A (en) Nicotinylalanine as a therapeutic agent acting on the central nervous system
EP0110224A2 (de) Benzoylthioverbindungen, ihre Herstellung und Verwendung als Arzneimittel
CN113402414A (zh) 一种苯甲酸衍生物及其制法和药物用途
EP0749957B1 (en) Aromatic hydroxamic acid compounds, their production and use
DE69829654T2 (de) Verfahren zur herstellung von rhizoferrin
US4288441A (en) Nicotinoyl pantetheine derivatives
JP7659634B2 (ja) 薬物コンジュゲート、その調製方法、及びその使用
DE69929802T2 (de) Lta4 hydrolase-hemmer
US3853954A (en) Tyrosine derivatives
KR810001274B1 (ko) 페닐글리신 유도체의 제조방법
JPH0353296B2 (2)
US4207337A (en) Relieving hypertension with carboxyalkylacylamino acids
CA2638175A1 (en) Methods for treating or preventing neuroinflammation or autoimmune disease
KR20010001219A (ko) 신규 아세트아미노펜 유도체 및 제조방법